MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

K.J. Lenos, J.A.C.M. Goos, I.M. Vuist, S.H. den Uil, P.M. Delis-van Diemen, E.J.T. Belt, H.B.A.C. Stockmann, H. Bril, M. de Wit, B. Carvalho, S. Giblett, C.A. Pritchard, G.A. Meijer, Y. van Kooyk, R.J.A. Fijneman, S.J. van Vliet

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)26278-26290
JournalOncotarget
Volume6
Issue number28
DOIs
Publication statusPublished - 2015

Cite this

Lenos, K.J. ; Goos, J.A.C.M. ; Vuist, I.M. ; den Uil, S.H. ; Delis-van Diemen, P.M. ; Belt, E.J.T. ; Stockmann, H.B.A.C. ; Bril, H. ; de Wit, M. ; Carvalho, B. ; Giblett, S. ; Pritchard, C.A. ; Meijer, G.A. ; van Kooyk, Y. ; Fijneman, R.J.A. ; van Vliet, S.J. / MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. In: Oncotarget. 2015 ; Vol. 6, No. 28. pp. 26278-26290.
@article{60fb1ef9158541818f6f54ccff190119,
title = "MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients",
author = "K.J. Lenos and J.A.C.M. Goos and I.M. Vuist and {den Uil}, S.H. and {Delis-van Diemen}, P.M. and E.J.T. Belt and H.B.A.C. Stockmann and H. Bril and {de Wit}, M. and B. Carvalho and S. Giblett and C.A. Pritchard and G.A. Meijer and {van Kooyk}, Y. and R.J.A. Fijneman and {van Vliet}, S.J.",
year = "2015",
doi = "10.18632/oncotarget.4495",
language = "Undefined/Unknown",
volume = "6",
pages = "26278--26290",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "28",

}

Lenos, KJ, Goos, JACM, Vuist, IM, den Uil, SH, Delis-van Diemen, PM, Belt, EJT, Stockmann, HBAC, Bril, H, de Wit, M, Carvalho, B, Giblett, S, Pritchard, CA, Meijer, GA, van Kooyk, Y, Fijneman, RJA & van Vliet, SJ 2015, 'MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients' Oncotarget, vol. 6, no. 28, pp. 26278-26290. https://doi.org/10.18632/oncotarget.4495

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. / Lenos, K.J.; Goos, J.A.C.M.; Vuist, I.M.; den Uil, S.H.; Delis-van Diemen, P.M.; Belt, E.J.T.; Stockmann, H.B.A.C.; Bril, H.; de Wit, M.; Carvalho, B.; Giblett, S.; Pritchard, C.A.; Meijer, G.A.; van Kooyk, Y.; Fijneman, R.J.A.; van Vliet, S.J.

In: Oncotarget, Vol. 6, No. 28, 2015, p. 26278-26290.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

AU - Lenos, K.J.

AU - Goos, J.A.C.M.

AU - Vuist, I.M.

AU - den Uil, S.H.

AU - Delis-van Diemen, P.M.

AU - Belt, E.J.T.

AU - Stockmann, H.B.A.C.

AU - Bril, H.

AU - de Wit, M.

AU - Carvalho, B.

AU - Giblett, S.

AU - Pritchard, C.A.

AU - Meijer, G.A.

AU - van Kooyk, Y.

AU - Fijneman, R.J.A.

AU - van Vliet, S.J.

PY - 2015

Y1 - 2015

U2 - 10.18632/oncotarget.4495

DO - 10.18632/oncotarget.4495

M3 - Article

VL - 6

SP - 26278

EP - 26290

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 28

ER -